Medical oncology
1 – 10 of 438
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
-
CYP3A7*1C allele : linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers
Johnson, Nichola ; Augustinsson, Annelie LU ; Brenner, Hermann LU ; Burwinkel, Barbara ; Hall, Per LU ; Olsson, Håkan LU
and Fletcher, Olivia
(2021)
In British Journal of Cancer
124(4).
p.842-854
Mark
-
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers
Glubb, Dylan M ; Olsson, Håkan LU
and O’Mara, Tracy A.
(2021)
In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
30(1).
p.217-228
Mark
- Association between anthropometry and lifestyle factors and risk of B-cell lymphoma : An exposome-wide analysis
- Newly diagnosed and relapsed follicular lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Adjuvant imatinib for GIST : duration likely matters
- How should we use ibrutinib in patients with mantle cell lymphoma?
- Detecting deviations from the efficacy and safety results of single-arm trials using real-world data : The case of a CAR-T cell therapy in B-cell lymphoma
- Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study
-
Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014 : A population-based cohort study
Leandersson, Pia LU
; Hogberg, Thomas
LU
; Dickman, Paul W.
; Malander, Susanne
LU
and Borgfeldt, Christer
LU
(2021)
In BMC Cancer
21(1).
Mark